| 1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults … L Hammitt, D Quinn, E Janczewska, FJ Pasquel, R Tytus, ... Open Forum Infectious Diseases 8 (Supplement_1), S616-S617, 2021 | | 2021 |
| 1084Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents X Saez-Llorens, DCA Vaca, K Abarca, E Maho, L Han, I Smolenov, P Dull Open Forum Infectious Diseases 1 (Suppl 1), S319, 2014 | | 2014 |
| 23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010 ME Ripoll, BMT Valenzuela, FR Vergara, VK Abarca, MA Muñoz, ... Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de …, 2010 | 4 | 2010 |
| 656 Immunogenicity and Safety Evaluation of a New Syringe Presentation of Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine in Healthy Adolescents: Results … M De La O, K Abarca, A Lepetic, K Hardt, G Jayadeva, S Kuriyakose, ... Open Forum Infectious Diseases 1 (suppl_1), S184-S184, 2014 | | 2014 |
| A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize delta and omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... medRxiv, 2021.11. 16.21266350, 2021 | 11 | 2021 |
| A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2 BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... medRxiv, 2021 | 2 | 2021 |
| A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... MBio 13 (4), e01423-22, 2022 | 30 | 2022 |
| A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the … P Fernández, A Trenholme, K Abarca, MP Griffin, M Hultquist, B Harris, ... BMC pediatrics 10, 1-13, 2010 | 45 | 2010 |
| A Third Amblyomma Species and the First Tick-Borne Rickettsia in Chile K Abarca, J López, G Acosta-Jamett, P Lepe, JF Soares, MB Labruna Journal of medical entomology 49 (1), 219-222, 2012 | 51 | 2012 |
| Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection AE González, MK Lay, EL Jara, JA Espinoza, RS Gómez, J Soto, ... Virulence 8 (6), 685-704, 2017 | 25 | 2017 |
| Absence of convincing evidence of Coxiella burnetii infection in Chile: a cross-sectional serosurvey among healthy adults in four different regions T Weitzel, J López, G Acosta-Jamett, S Edouard, P Parola, K Abarca BMC Infectious Diseases 16, 1-6, 2016 | 15 | 2016 |
| Accuracy and diagnostic utility of IgM in Bartonella henselae infections K Abarca, M Winter, D Marsac, C Palma, AM Contreras, M Ferres Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de …, 2013 | 18 | 2013 |
| Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program VK Abarca, LJ Cerda, RC Ferreccio Revista Medica de Chile 137 (1), 10-17, 2009 | 4 | 2009 |
| Agentes emergentes de importancia zoonótica en caninos en Chile K Abarca Universidad de Chile. Facultad de Ciencias Veterinarias y Pecuarias, 2012 | | 2012 |
| An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile JA Soto, F Melo-González, C Gutierrez-Vera, BM Schultz, ... medRxiv, 2022.02. 15.22270973, 2022 | 4 | 2022 |
| An update on host-pathogen interplay and modulation of immune responses during Orientia tsutsugamushi infection FE Díaz Acevedo, K Abarca Villaseca | | 2018 |
| An update on host-pathogen interplay and modulation of immune responses during Orientia tsutsugamushi infection FE Díaz, K Abarca, AM Kalergis Clinical microbiology reviews 31 (2), 10.1128/cmr. 00076-17, 2018 | 43 | 2018 |
| Anaplasma platys in dogs, Chile K Abarca, J López, C Perret, J Guerrero, P Godoy, A Veloz, ... Emerging Infectious Diseases 13 (9), 1392, 2007 | 100 | 2007 |
| Ántrax (carbunco) C Perret, L Maggi, C Pavletic, R Vergara, K Abarca, J Dabanch, ... Revista chilena de infectología 18 (4), 291-299, 2001 | 24 | 2001 |
| Aproximación clínica y principales rickettsiosis transmitidas por garrapatas presentes en Latinoamérica K Abarca Villaseca, J Oteo | | 2014 |
